Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma.
about
Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease.Cross-talk between p21-activated kinase 4 and ERα signaling triggers endometrial cancer cell proliferation.Rho GTPase effectors and NAD metabolism in cancer immune suppression.Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia.Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes.
P2860
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma.
@en
type
label
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma.
@en
prefLabel
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma.
@en
P2093
P2860
P50
P1433
P1476
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma
@en
P2093
Aldo Roccaro
Annamaria Gulla
Barry Karger
Christian Argueta
Erkan Baloglu
Mariateresa Fulciniti
Mehmet K Samur
Monica Schenone
Nicola Amodio
Nikhil C Munshi
P2860
P304
P356
10.1182/BLOOD-2016-06-724831
P407
P577
2017-01-17T00:00:00Z